<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02912429</url>
  </required_header>
  <id_info>
    <org_study_id>PF-Arthroplasty 1</org_study_id>
    <nct_id>NCT02912429</nct_id>
  </id_info>
  <brief_title>Onlay vs. Inlay Patellofemoral Arthroplasty</brief_title>
  <official_title>Onlay- vs. Inlay-Type Patellofemoral Arthroplasty: a Prospective, Comparative Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University Innsbruck</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University Innsbruck</source>
  <brief_summary>
    <textblock>
      There is currently no sufficient evidence if there is superiority of one of the two available
      types (onlay type, inlay type) of patellofemoral arthroplasty. Therefore, it is the aim of
      this study to compare the two types in a prospective comparative setting. Patients on the
      waiting list for patellofemoral arthroplasty are randomized to either onlay or inlay type
      patellofemoral arthroplasty. The KOOS - knee score serves as the primary outcome parameter.
      Secondary outcome parameters are the Marx Activity Scale, the HSS patella score, the Kujala
      Score, radiographic loosening, progression of tibiofemoral degeneration, revision surgery and
      parameters of patellofemoral tracking. Inferential statistics will be performed at 1-year
      follow up data-sets.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2016</start_date>
  <primary_completion_date type="Anticipated">January 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>KOOS knee score</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Kujala Score</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Marx Activity Scale</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HSS patella Score</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>radiolucent lines adjacent to the prosthesis</measure>
    <time_frame>20 years</time_frame>
    <description>radiolucent lines adjacent to the prosthesis indicate prosthesis loosening</description>
  </other_outcome>
  <other_outcome>
    <measure>revision of prosthesis</measure>
    <time_frame>20 years</time_frame>
    <description>reoperations with ex/implantation of implants are defined as prosthetic revision</description>
  </other_outcome>
  <other_outcome>
    <measure>progression of tibiofemoral osteoarthritis</measure>
    <time_frame>20 years</time_frame>
    <description>progression of tibiofemoral osteoarthritis is assessed in terms of IKDC grades A-D</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Patellofemoral Joint</condition>
  <condition>Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Inlay</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>specific technical type of patellofemoral arthroplasty</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Onlay</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>specific technical type of patellofemoral arthroplasty</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Patellofemoral Arthroplasty</intervention_name>
    <arm_group_label>Inlay</arm_group_label>
    <arm_group_label>Onlay</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patellofemoral osteoarthritis, waiting list for patellofemoral arthroplasty

        Exclusion Criteria:

          -  systemic inflammatory arthropathy

          -  tibiofemoral joint degeneration IKDC grade C or worse

          -  severe degeneration of also the trochlea margins (inlay PFA not adequate)

          -  patellectomy

          -  previous implantation of tibiofemoral metal implants

          -  extension loss &gt;5 degree

          -  knee flexion of less than 100Â°

          -  planned concomitant tibiofemoral procedures (eg. coronal plane osteotomies,
             tibiofemoral cartilage procedures, tibiofemoral ligament procedures)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>120 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>michael liebensteiner</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University Innsbruck</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>michael C Liebensteiner</last_name>
    <phone>+43 512 504</phone>
    <phone_ext>80547</phone_ext>
    <email>michael.liebensteiner@i-med.ac.at</email>
  </overall_contact>
  <location>
    <facility>
      <name>Medical University Innsbruck</name>
      <address>
        <city>Innsbruck</city>
        <state>Tyrol</state>
        <zip>6020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael C Liebensteiner, Professor</last_name>
      <phone>+43 512 504 80547</phone>
      <email>michael.liebensteiner@i-med.ac.at</email>
    </contact>
    <investigator>
      <last_name>Michael C Liebensteiner</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2016</study_first_submitted>
  <study_first_submitted_qc>September 20, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 23, 2016</study_first_posted>
  <last_update_submitted>September 26, 2016</last_update_submitted>
  <last_update_submitted_qc>September 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 27, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University Innsbruck</investigator_affiliation>
    <investigator_full_name>Michael Liebensteiner</investigator_full_name>
    <investigator_title>Principal Investigator and Coordinating Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

